06/07
Headlines

NASDAQ:GERN

Biotech Volatile Stocks: Geron Corporation (NASDAQ:GERN), Novavax (NASDAQ:NVAX), Aegerion Pharmaceuticals (NASDAQ:AEGR), CytRx Corporation (NASDAQ:CYTR)

Kevin Long02 mins

Geron Corp. (NASDAQ:GERN) stock had its “positive” rating reiterated by equities research analysts at Wells Fargo & Co. in a research note issued to investors on Thursday, American Banking News.com reports.Geron Corporation (NASDAQ:GERN) stock performance was -2.73% in last session and finished the day at $1.78. Traded volume was 7,214,860 million shares in the last…

Read More

Biotech Active Stocks: Pfizer Inc. (NYSE:PFE), Geron Corporation (NASDAQ:GERN), Cell Therapeutics (NASDAQ:CTIC), Chelsea Therapeutics International (NASDAQ:CHTP)

John Bellich02 mins

A US federal court yesterday invalidated Pfizer Inc.’s (NYSE:PFE) key patent covering its anti-inflammatory pill Celebrex. The patent, which was set to lapse in December 2015, would have given Pfizer an 18-month extension from the expiry of the patent for the major ingredient in the drug, celecoxib. Pfizer Inc. (NYSE:PFE) stock performance was -2.69% in…

Read More

Biotech Gainers: Geron Corporation (NASDAQ:GERN), Chelsea Therapeutics International (NASDAQ:CHTP), TESARO Inc (NASDAQ:TSRO), Vanda Pharmaceuticals (NASDAQ:VNDA)

Mark DeFrance02 mins

Geron Corp. (NASDAQ:GERN)‘s stock had its “positive” rating reaffirmed by equities researchers at Wells Fargo & Co. in a research report issued on Thursday, AnalystRatings.NETreports. Geron Corporation (NASDAQ:GERN) stock performance was 5.62% in last session and finished the day at $1.78. Traded volume was 16,397,352 million shares in the last session and the average volume…

Read More

Biotech Most Active Stocks: Geron Corporation (NASDAQ:GERN), Pfizer Inc. (NYSE:PFE), OXiGENE Inc (NASDAQ:OXGN), Gilead Sciences (NASDAQ:GILD)

Kevin Long02 mins

Geron Corporation (NASDAQ:GERN)  got bad news about its key imetelstat drug, as the FDA issued a clinical hold on the treatment for multiple myeloma and essential thrombocythemia. Geron Corporation (NASDAQ:GERN) stock performance was -61.59% in last session and finished the day at $1.69. Traded volume was 46,444,384 million shares in the last session and the…

Read More

Biotech Top Losers: Geron Corporation (NASDAQ:GERN), Synta Pharmaceuticals (NASDAQ:SNTA), Northwest Biotherapeutics (NASDAQ:NWBO), AEterna Zentaris (NASDAQ:AEZS)

Chris Lewis02 mins

Geron Corporation (NASDAQ:GERN) said the US Food and Drug Administration ordered a halt to trials of a cancer drug over concerns about potential liver damage. Geron Corporation (NASDAQ:GERN) stock performance was -61.59% in last session and finished the day at $1.69. Traded volume was 46,444,384 million shares in the last session and the average volume…

Read More

Moving Stocks: Geron Corporation (NASDAQ:GERN), Alcatel Lucent SA (ADR) (NYSE:ALU), CenterState Banks, Inc. (NASDAQ:CSFL), Highpower International, Inc. (NASDAQ:HPJ), Ensco plc (NYSE:ESV)

Kristen Barton03 mins

Geron Corp (NASDAQ:GERN) reported Q3 EPS of ($0.06), in-line with the analyst estimate of ($0.06). Revenue for the quarter came in at $160 thousand versus the consensus estimate of $240 thousand. The company also announced that the U.S. Food and Drug Administration (FDA) has removed the full clinical hold on Geron’s investigational new drug (IND)…

Read More